Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0006675,
umls-concept:C0006772,
umls-concept:C0006776,
umls-concept:C0016315,
umls-concept:C0018787,
umls-concept:C0021467,
umls-concept:C0021469,
umls-concept:C0025234,
umls-concept:C0030685,
umls-concept:C0031441,
umls-concept:C0036226,
umls-concept:C0041485,
umls-concept:C0072847,
umls-concept:C0150312,
umls-concept:C0205102,
umls-concept:C0243076,
umls-concept:C0391871,
umls-concept:C0444706,
umls-concept:C0680255,
umls-concept:C1283071,
umls-concept:C1707271,
umls-concept:C1963578,
umls-concept:C2825407
|
pubmed:issue |
3
|
pubmed:dateCreated |
1986-11-7
|
pubmed:abstractText |
Calcium dissociation from the C-terminal and N-terminal halves of calmodulin, intact bovine brain calmodulin and the respective phenoxybenzamine complexes or melittin complexes was measured directly by stopped-flow fluorescence with the calcium chelator Quin 2 and, when possible, also by protein fluorescence using endogenous tyrosine fluorescence by mixing with EGTA. Calcium dissociation from the C-terminal half of calmodulin, which contains only the two high-affinity calcium-binding sites, and from intact calmodulin was monophasic, with good correlation of the rates of calcium dissociation obtained by the two methods. The apparent rates with Quin 2 and endogenous tyrosine fluorescence were 13.4 s-1 and 12.8 s-1, respectively, in the C-terminal half and 10.5 s-1 and 10.8 s-1, respectively, in intact calmodulin (pH 7.0, 25 degrees C, 100 mM KCl). Alkylation of the C-terminal half resulted in a biphasic calcium dissociation (Quin 2: kobs 1.90 s-1 and 0.73 s-1 respectively; tyrosine: kobs 1.65 s-1 and 0.61 s-1 respectively). Alkylation of intact calmodulin resulted in a four-phase calcium dissociation measured with Quin 2 (kobs 85.3 s-1, 11.1 s-1, 1.92 s-1 and 0.59 s-1); the latter two phases are assumed to represent calcium release from high-affinity sites since they correspond to the biphasic tyrosine fluorescence change in intact alkylated calmodulin (kobs 2.04 s-1 and 0.53 s-1 respectively) and the rate parameters determined in the C-terminal half. Evidently perturbation of the calcium-binding sites by alkylation reduces the rate of calcium dissociation and allows a distinction to be made between dissociation from each of the two high-affinity sites as well as the distinct conformational change on dissociation of each calcium. Alkylation of the N-terminal half resulted in biphasic calcium release with rates (kobs 153 s-1 and 10.9 s-1 respectively) similar to those observed in intact alkylated calmodulin. The rates of calcium dissociation from calmodulin-melittin or fragment-melittin complexes, measured with Quin 2, were slower and monophasic in the C-terminal half (kobs 1.12 s-1), biphasic in the N-terminal half (kobs 140 s-1 and 26.8 s-1 respectively) and triphasic in intact calmodulin (kobs 126 s-1, 12.1 s-1 and 1.38 s-1). Calmodulin antagonists thus increase the apparent calcium affinity of high and low-affinity sites mainly due to a reduced calcium 'off rate', presumably because of conformation restrictions.(ABSTRACT TRUNCATED AT 400 WORDS)
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Aminoquinolines,
http://linkedlifedata.com/resource/pubmed/chemical/Bee Venoms,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium,
http://linkedlifedata.com/resource/pubmed/chemical/Calmodulin,
http://linkedlifedata.com/resource/pubmed/chemical/Melitten,
http://linkedlifedata.com/resource/pubmed/chemical/Peptide Fragments,
http://linkedlifedata.com/resource/pubmed/chemical/Phenoxybenzamine,
http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Quin2,
http://linkedlifedata.com/resource/pubmed/chemical/Tyrosine
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0014-2956
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
159
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
425-34
|
pubmed:dateRevised |
2007-7-23
|
pubmed:meshHeading |
pubmed-meshheading:3758070-Aminoquinolines,
pubmed-meshheading:3758070-Animals,
pubmed-meshheading:3758070-Bee Venoms,
pubmed-meshheading:3758070-Calcium,
pubmed-meshheading:3758070-Calmodulin,
pubmed-meshheading:3758070-Dogs,
pubmed-meshheading:3758070-Enzyme Activation,
pubmed-meshheading:3758070-Melitten,
pubmed-meshheading:3758070-Myocardium,
pubmed-meshheading:3758070-Peptide Fragments,
pubmed-meshheading:3758070-Phenoxybenzamine,
pubmed-meshheading:3758070-Protein Binding,
pubmed-meshheading:3758070-Protein Conformation,
pubmed-meshheading:3758070-Protein Kinase Inhibitors,
pubmed-meshheading:3758070-Sarcoplasmic Reticulum,
pubmed-meshheading:3758070-Spectrometry, Fluorescence,
pubmed-meshheading:3758070-Tyrosine
|
pubmed:year |
1986
|
pubmed:articleTitle |
Calcium release from calmodulin and its C-terminal or N-terminal halves in the presence of the calmodulin antagonists phenoxybenzamine and melittin measured by stopped-flow fluorescence with Quin 2 and intrinsic tyrosine. Inhibition of calmodulin-dependent protein kinase of cardiac sarcoplasmic reticulum.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|